Company Information

UNJHA FORMULATIONS LTD.

NSE : NABSE : 531762ISIN CODE : INE576D01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE23.531.12 (+5 %)
PREV CLOSE ( ) 22.41
OPEN PRICE ( ) 21.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12565
TODAY'S LOW / HIGH ( )21.75 23.53
52 WK LOW / HIGH ( ) 10.5534.99
NSE
This Company is not listed in NSE
ChairmanJashodaben S Patel
Managing DirectorKrutiben M Patel
Company SecretaryJigar Ray
Additional DirectorEsha Mayank Patel
Non Executive Independent DirectorHasmukh S Darji
Jitendra P Limbachiya
Mustufa Najmuddin Jodhpurwala
Incorporation Year : 1994

Registered Office :

Address : Khali Char Rasta,State Highway, Sidhpur,
Gujarat-384151 .

Phone : 02767- 282395 / 282396 / 282464 / 9825069590 / 9825017696

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.